0 Bewertungen0% fanden dieses Dokument nützlich (0 Abstimmungen)
47 Ansichten2 Seiten
ACTIVE IMMUNIZATION OF INFANTS AND CHILDRENS Bacillus Calmette-Guerin (BCG) AGE Newborn DOSE 0.05 ml ID ROUTE CONTRAINDICATIONS Immune deficiency, progressive dermatoses ADVERSE REACTION Abscess or ulcers at site of injection; lymphadenopathy which may caseate; disseminated BCG 0. / 100,000 vaccines; BCG 0.1-0.
ACTIVE IMMUNIZATION OF INFANTS AND CHILDRENS Bacillus Calmette-Guerin (BCG) AGE Newborn DOSE 0.05 ml ID ROUTE CONTRAINDICATIONS Immune deficiency, progressive dermatoses ADVERSE REACTION Abscess or ulcers at site of injection; lymphadenopathy which may caseate; disseminated BCG 0. / 100,000 vaccines; BCG 0.1-0.
Copyright:
Attribution Non-Commercial (BY-NC)
Verfügbare Formate
Als DOC, PDF, TXT herunterladen oder online auf Scribd lesen
ACTIVE IMMUNIZATION OF INFANTS AND CHILDRENS Bacillus Calmette-Guerin (BCG) AGE Newborn DOSE 0.05 ml ID ROUTE CONTRAINDICATIONS Immune deficiency, progressive dermatoses ADVERSE REACTION Abscess or ulcers at site of injection; lymphadenopathy which may caseate; disseminated BCG 0. / 100,000 vaccines; BCG 0.1-0.
Copyright:
Attribution Non-Commercial (BY-NC)
Verfügbare Formate
Als DOC, PDF, TXT herunterladen oder online auf Scribd lesen
Newborn 0.05 ml ID Immune deficiency, Abscess or ulcers at
progressive dermatoses site of injection; lymphadenopathy which may caseate; disseminated BCG >1 month 0.1 ml 0.1/100,000 vaccines; BCG 0.1-0.3/100,000 vaccines
DIPTHERIA-TETANUS AND PERTUSSIS VACCINE (DTP)
6, 10, 14 0.5 ml IM Acute febrile illness Paralysis (0.06 million
weeks associated with doses among convulsions or other recipients; 0.14 million Booster: severe reactions doses among contracts 15-16 (anaphylaxis or of recipients) months collapse) to previous dose of DTP 4-6 years
TRIVALENT ORAL POLIO-VIRUS VACCINE (TOVP)
6, 10, 14 0.5 ml PO Altered immune states Paralysis (0.06 million
weeks (leukemia, lymphoma, doses among malignancy, therapy recipients; 0.14 million Booster: with alkylating drugs, doses among contracts 15-16 radiation of recipients) months antimetabolites, steroids 4-6 years
DTP + INACTIVATED POLIOVIRUS (IPV) VACCINE
6, 10, 14 0.5 ml IM Acute febrile illnesses Fever, local reaction,
weeks erythema, pain, edema
15-16 months
4-6 years
ATTENUATED MEASLES VACCINE (Ddmonston Zagreb strain) GIVEN 6 MONTHS OR
LIVE FURTHER ATTENUATED (Schwartz strain) MEASLES VIRUS VACCINE GIVEN AT 9 MONTHS; MEASLES, MUMPS, RUBELLA VIRUS VACCINE GIVEN AT 15 MONTHS
6 months 0.5 ml SC Altered immune state Local reaction
as listed above simulating an Arthus phenomenon, 1-8 days Acute febrile illness after vaccination; Untreated active Fever with or without 9 months 0.5 ml SC tuberculosis measles-like manifestations about Immunoglobulin the 6th -12th day after administration within 3 vaccination months Fever; malaise; Marked hypersensitivity encephalitis; skin to vaccine components; eruptions allergy to eggs, Pregnancy
Soon after At birth:one IM Hypersensitivity to any Local reactions include
birth if month and six component of the erythema, swelling and mother is months old vaccine warmth HBsAg+; (dose depends if not 6 on Systemic complaints weeks old manufacturer’s include fever, malaise, recommendati fatigue, headache, on) dizziness, myalgia and nausea